Hypoxia inhibits MHC I expression and antigen presentation to escape immune surveillance
Hypoxia is a common feature of solid tumors that has previously been linked to resistance to radiotherapy and chemotherapy, and more recently to immunotherapy. In particular, hypoxic tumors exclude T cells and inhibit their activity, suggesting that tumor cells acquire a mechanism to evade T cell re...
Hauptverfasser: | Estephan, H, Tailor, A, Parker, R, Kreamer, M, Papandreou, I, Campo, L, Easton, A, Moon, EJ, Denko, N, Ternette, N, Hammond, E, Giaccia, A |
---|---|
Format: | Journal article |
Sprache: | English |
Veröffentlicht: |
EMBO Press
2025
|
Ähnliche Einträge
Ähnliche Einträge
-
Mass spectrometry–based identification of MHC-bound peptides for immunopeptidomics
von: Purcell, A, et al.
Veröffentlicht: (2019) -
MHC antigens and cancer: implications for T-cell surveillance.
von: Browning, M, et al.
Veröffentlicht: (1992) -
Hypoxia-mediated regulation of DDX5 through decreased chromatin accessibility and post-translational targeting restricts R-loop accumulation
von: Leszczynka, K, et al.
Veröffentlicht: (2023) -
Dual roles of NRF2 in tumor prevention and progression: possible implications in cancer treatment
von: Moon, EJ, et al.
Veröffentlicht: (2014) -
Identification of antigens presented by MHC for vaccines against tuberculosis
von: Bettencourt, P, et al.
Veröffentlicht: (2020)